Panic-like selling emerges early Monday as Dow skids 2% lower, eyes sharpest selloff in 2 months
Trading in New York Stock Exchange-listed stocks on Monday were exhibiting panic-like-selling behavior as global stocks confronted…
Cytek BioSciences could be valued at more than $2.3 billion as IPO terms have been set
Cytek BioSciences Inc. has set terms for its initial public offering, in which the California-based cell analysis company could…
Ingersoll Rand confirms $3.6 billion buyout bid for SPX Flow was made, and rejected last month
Shares of SPX Flow Inc. soared 24% toward record territory in premarket trading Monday, after the Ingersoll Rand Inc….
Snap One looks to raise up to $291 million, to be valued at up to $1.6 billion as IPO terms were set
Snap One Holdings Corp. has set terms for its initial public offering, in which the North Carolina-based provider of…
Need to Know: COVID-19 cases may cause an S&P 500 correction, analyst says. Buy these stocks in the next dip.
It’s a rough start to the week for markets. Stocks sold off in Asia and Europe, with Dow industrials…
Market Snapshot: Dow futures drop over 300 points as spread of delta variant continues
Stock-index futures point to a lower start Monday, with concerns about the global spread of the delta variant of…
Cal-Maine reports a surprise loss, as egg prices dropped amid lifting of COVID-19 restrictions
Cal-Maine Foods Inc. reported Monday a surprise fiscal fourth-quarter loss and revenue that fell below expectations, with egg…
Earnings Watch: What does a mature streaming service look like? Netflix is about to show us
Earnings Watch: Netflix expects its worst quarter but could follow many different paths when it reports results ahead of…
Panic-like selling emerges Friday afternoon as stock market’s drop gathers steam in last hour of trade
Trading in New York Stock Exchange-listed stocks on Friday were exhibiting panic-like-selling behavior to end a turbulent week…
Kadmon’s graft-versus-host treatment gets FDA approval
Kadmon Holdings Inc. said Friday that Rezurock, its treatment of chronic graft-versus-host disease (cGVHD) in adjusts and pediatric…
recent post
-
-
Nov 10 2025
-
-
Nov 10 2025
-
Nov 10 2025
